Lifecare AS – New share capital registered

Reference is made to the stock exchange announcement published on 26 October
2022 by Lifecare AS (the "Company") announcing the successful completion of a
private placement of new shares in the Company, with gross proceeds of NOK 45
million (the "Private Placement").
 
The share capital increase related to the Private Placement has been registered
in the Norwegian Register of Business Enterprises, and the Company's new
registered share capital is NOK 47,146,296.80 divided into 117,865,742 shares,
each with a par value of NOK 0.40.


For further information, please contact:

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.This stock exchange announcement
was published by Joacim Holter, CEO at Lifecare AS, on 03.11.2022 at 21.58 CET.

This is Lifecare

Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE).